Public Policy Page Contents
- PSAB Documents (Statements, Reports, Testimony and Monthly Newsletters)
- Research and Development Funding for FY 2014
- Contact Congress (Legislative Action Center)
- Clinical Microbiology Resources
- Public and Scientific Affairs Board Information
- Federal and State Government Links
- Congressional Science Fellowship
Check Here for Critical Public Policy Information
- Sentinel Level Clinical Laboratory Protocols For Suspected Biological Threat Agents And Emerging Infectious Diseases
- Committee on the Status of Women in Microbiology
- Committee on Microbiological Issues Impacting Minorities
Public and Scientific Affairs Board (PSAB)
Underlying the ASM's dedication to the advancement of scientific knowledge is its commitment that science serve the public interest. To address scientific matters affecting the public interest, the ASM created the Public and Scientific Affairs Board (PSAB) in 1979. The PSAB monitors legislation and regulation and develops positions for the Society on public policy issues. The PSAB encourages the adoption of sound policies affecting science and technology and the discipline of microbiology. The PSAB responds to policy makers who may request or require an understanding of research and technology in microbiology. It also communicates microbiological issues to the public.
What's New in Public Policy?
The February issue of the e-Public Policy Update has been published by the Office of Public Affairs. The content of this page is restricted to ASM Members only.Please login at the top-right or to become a member, join ASM.
The February issue of the Minority Microbiology Mentor has been published by the Committee on Microbiological Issues Impacting Minorities. The content of this page is restricted to ASM Members only.Please login at the top-right or to become a member, join ASM.
Dr. Timothy Donohue, President Elect of ASM, spoke about microbiology and ASM during the public comment session of the NIGMS Council meeting on January 24, 2014.
The January issue of the Clinical Microbiology Issues Update has been published by the Office of Public Affairs. The content of this page is restricted to ASM Members only.Please login at the top-right or to become a member, join ASM.
The ASM submitted a letter to the Senate Committee on Homeland Security and Governmental Affairs as part of the hearing record for its January 14 hearing entitled “Examining Conference and Travel Spending Across the Federal Government.”
Omnibus Appropriations Bill Increases Research FundingHouse and Senate appropriations committees released an FY 2014 omnibus appropriations bill on January 13 that would fund the federal government through September and restores some of the funding lost to the across-the-board cuts from sequestration. The bill includes all 12 FY 2014 spending bills.
The ASM sent funding recommendations to the Budget Conference Committee. The Budget Conference Committee has a December 13, 2013, deadline to negotiate the differences in spending levels for FY 2014 between the House and the Senate and to issue a report.
On October 17, HR. 2775 the “Continuing Appropriations Resolution of 2014” was signed into law by the President, extending the debt ceiling through February 7, 2014 and temporarily restoring funding for government agencies. This page includes an analysis of the bill.
October 5, 2013 - ASM Comments on CMS National Coverage Analysis for Screening for Hepatitis C Virus
The ASM submitted comments to the Centers for Medicare & Medicaid Services supporting proposals in “National Coverage Analysis (NCA) for Screening for Hepatitis C Virus (HCV) in Adults (CAG-00436N).”
ASM provided comments to the Centers for Medicare & Medicaid Services (CMS) regarding proposed revisions to payment policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule & Other Revisions to Part B for CY 2014 [CMS-1600-P] published in the Federal Register on July 19, 2013. ASM commented specifically on...